# PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers

> clinical trial · VERIFIED · 2026-07-28

Status: NOT_YET_RECRUITING · Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation · Condition: Subjective Cognitive Decline (SCD)

- Company: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT07730671

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.